Who Paid My Doc
Proclaim
Device Neuromodulation
PDI 05415067020239
General payments
$8,703,492
Research payments
$1,079,555
Through program year 2025, $8,703,492 in general payments and $1,079,555 in research payments were reported against Proclaim (Neuromodulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $147,298 | 26 |
| 2024 | General | $1,990,054 | 19,195 |
| 2024 | Research | $241,200 | 164 |
| 2023 | General | $2,991,083 | 34,252 |
| 2023 | Research | $345,648 | 167 |
| 2022 | General | $3,722,356 | 59,447 |
| 2022 | Research | $345,409 | 191 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 142 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 53 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
112,894 general · 548 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.